NSE: CIPLA · 18 November 2026
CIPLA LTD F&O Intelligence
Data-mining view of cash participation, delivery, futures activity, open interest and recent positioning.
Last 3 Sessions: Cash Activity & Delivery
| Date | Cash Volume | Number of Trades | Shares Traded per Trade | Delivery % | Close / Change |
|---|---|---|---|---|---|
| 16 Nov | 12.49 L shares | 41,090 | 30.4 WittyTrades Proprietary |
60.50% | Rs 1,394.50 (+0.19%) |
| 17 Nov | 10.17 L shares | 38,265 | 26.6 WittyTrades Proprietary |
62.34% | Rs 1,388.00 (-0.47%) |
| 18 Nov | 29.09 L shares | 72,754 | 40.0 WittyTrades Proprietary |
33.26% | Rs 1,417.00 (+2.09%) |
Average number of shares traded per trade was 40.0 in the latest session versus a 32.3 3-session average. The latest average trade size was materially above its 3-session baseline, which can flag stronger larger-ticket or institutional-style participation. Latest delivery was 33.3% versus a 3-session average of 52.0%.
Last 3 Sessions: Futures vs Cash Participation
| Date | Near Future / Change | Futures Volume (Shares) | Cash Volume (Shares) | F&O/Cash Participation Ratio | Aggregate Futures OI | Positioning Read |
|---|---|---|---|---|---|---|
| 16 Nov | Rs 1,398.20 (-0.02%) | 7.21 L shares | 12.49 L shares | 0.58x WittyTrades Proprietary |
1.09 Cr shares (—) | Positioning unavailable |
| 17 Nov | Rs 1,388.50 (-0.69%) | 12.54 L shares | 10.17 L shares | 1.23x WittyTrades Proprietary |
1.12 Cr shares (+2.18%) | Short buildup |
| 18 Nov | Rs 1,421.80 (+2.40%) | 66.57 L shares | 29.09 L shares | 2.29x WittyTrades Proprietary |
1.12 Cr shares (+0.68%) | Long buildup |
How open interest shifted across expiries
| Expiry | Latest OI | 1-Day OI Change |
|---|---|---|
| 23 Nov | 72.40 L shares | -24.90 L |
| 29 Dec | 37.79 L shares | +25.69 L |
| 25 Jan | 2.29 L shares | -2,975 |
The front expiry lost OI while later expiries gained OI, confirming contract migration. About 35.6% of aggregate OI sat beyond the front expiry. This is an expiry-structure observation, not a directional signal by itself.
- Whether aggregate futures OI expands or contracts alongside the next price move.
- Whether the WittyTrades F&O/Cash Participation Ratio remains elevated or normalises.
- Whether Shares Traded per Trade moves materially above or below its recent baseline.
- Whether delivery participation holds above or below the recent 3-session average of 52.0%.
- Whether later-expiry OI continues to absorb positions from the front contract as expiry approaches.
Higher Shares Traded per Trade can flag larger-ticket participation, but exchange trade-count data does not identify the buyer or seller category. The F&O/Cash Participation Ratio measures participation intensity and does not by itself distinguish directional trading, hedging or arbitrage.
- Cipla Ltd shares advanced 2.09% during the trading session, settling at ₹1,417.00 after moving between an intraday low of ₹1,381.30 and a high of ₹1,435.00.
- Cipla provided an official update regarding the USFDA inspection at its InvaGen manufacturing facility located in Hauppauge, Long Island, New York, USA. The disclosure follows prior regulatory engagements concerning the overseas manufacturing plant.
- Trading volume was 1.98 times the 20-day average daily volume.
Why is CIPLA share price rising on 18 November 2026?
Cipla Ltd shares advanced 2.09% during the trading session, settling at ₹1,417.00 after moving between an intraday low of ₹1,381.30 and a high of ₹1,435.00.
The broader market faced downward pressure as the Nifty index declined 0.63%, while the sectoral benchmark Nifty Pharma posted a modest gain of 0.15%. Cipla outperformed both the broader index and its sector peers, supported by a healthy pickup in cash-market participation and strong relative strength compared to the wider pharmaceutical basket.
On the corporate front, market participants noted the ongoing operational developments surrounding the company, including recent updates regarding regulatory inspections at its overseas manufacturing facilities and management additions. While these ongoing updates provide broader business context, today's positive price action reflects solid buying interest and accumulation rather than a single immediate catalyst.
29.09 lakh shares traded by 18 November 2026 · 03:30 PM IST. This compares with a 20-day average daily volume of 14.70 lakh shares (1.98 times). The five-day average daily volume was 13.39 lakh shares. Separately, the NSE report for 18 November 2026 showed 9.68 lakh shares delivered, representing 33.26% of that day’s traded volume. The same report recorded 72,754 trades.
The upward move occurred amid higher-than-average cash volume and relative strength against a falling broader market, though no single same-day catalyst was explicitly linked to the session's gains.
Latest Company Developments
Cipla provided an official update regarding the USFDA inspection at its InvaGen manufacturing facility located in Hauppauge, Long Island, New York, USA. The disclosure follows prior regulatory engagements concerning the overseas manufacturing plant.
Regulatory compliance and facility audits at key international plants are critical for maintaining uninterrupted export operations and sustaining growth in the US generics market.
The company announced the appointment of Mr. Vikram Janakiraman as the Global Chief Technical Operating Officer, designated as a Senior Management Personnel effective from December 7, 2026. This addition aims to bolster operational and technical execution across global manufacturing networks.
Senior leadership changes in technical and operational roles are key to overseeing manufacturing excellence and navigating regulatory standards across key global markets.
Update on USFDA inspection at InvaGen manufacturing facility in Hauppauge, Long Island, NewYork, USA
a press release dated October 27, 2026, titled "Q2FY27 Financial Results".
Appointment of Ms Rashmi Joshi as Independent Director of the company effective. October 27, 2026.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 20.78% on 30 September 2026. This compares with 20.56% on 30 June 2026, a change of +0.22 percentage points.
The filing reported 46 MF/UTI holders.
What to Watch Next
- Developments regarding the USFDA inspection status at the InvaGen manufacturing facility
- Cash volume and delivery percentage trends relative to the 20-day average volume
- Performance against the Nifty Pharma sector benchmark
- Execution of operational goals under incoming senior technical management
Other Dated Coverage
- CIPLA Share Price Today: Why CIPLA Is Falling 0.37% | 27 October 2026 — 27 October 2026
- CIPLA Share Price Today: Why CIPLA Is Falling 0.44% | 23 October 2026 — 23 October 2026
- Why Cipla Shares Dropped 2.41% Today: Sector Trends & Outlook | 30 September 2026 — 30 September 2026
More CIPLA news and dated analysis →
Frequently Asked Questions
What is the latest CIPLA company news?
Cipla provided an official update regarding the USFDA inspection at its InvaGen manufacturing facility located in Hauppauge, Long Island, New York, USA. The disclosure follows prior regulatory engagements concerning the overseas manufacturing plant.
How strong was CIPLA’s trading volume?
29.09 lakh shares traded, 1.98 times the 20-day average daily volume. The price and volume data are dated 18 November 2026 · 03:30 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
SEBI Registration No.: INH000008172 · BSE Enlistment No.: 5430
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.
